BRVE insider buying and SEC filings, explained
Braveheart Bio, Inc. · CIK 2131524
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$89.2M
Insiders who bought
8
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Aug 7, 2026 | Purchase (code P) | Marc L Andreessen (10% owner) bought 1,100,000 shares indirectly (by entity) at $18.00 ($19.8M), reported as a purchase (code P). Holdings by entity up 12% to 10,232,420 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 3 other reporting owners. | SEC filing Filed Aug 11, 2026 |
| Aug 7, 2026 | Other purchase | Erez Chimovits (Director and 10% owner) bought 1,940,000 Common Stock indirectly at $18.00 ($34.9M) in a public offering. New position of 273,333 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 11, 2026 |
| Aug 7, 2026 | Other purchase | ORBIMED ADVISORS LLC (Director and 10% owner) bought 1,940,000 Common Stock indirectly at $18.00 ($34.9M) in a public offering. New position of 273,333 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 2 other reporting owners. | SEC filing Filed Aug 11, 2026 |
| Aug 7, 2026 | Purchase (code P) | Forbion Growth III Management B.V. (10% owner) bought 3,600,000 shares directly and indirectly (by entity) at $18.00 ($64.8M), reported as a purchase (code P). Direct holdings up 20% to 11,640,546 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 3 other reporting owners. | SEC filing Filed Aug 7, 2026 |
| Aug 7, 2026 | Purchase (code P) | James Paul Rickey (CFO) bought 27,777 shares at $18.00 ($500K), reported as a purchase (code P). Holdings up 6% to 520,927 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 7, 2026 |
| Aug 7, 2026 | Purchase (code P) | Christopher Viehbacher (Director) bought 83,333 shares at $18.00 ($1.5M), reported as a purchase (code P). Holdings up 16% to 609,519 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 7, 2026 |
| Aug 7, 2026 | Purchase (code P) | David I Malek (Director) bought 4,166 shares at $18.00 ($75K), reported as a purchase (code P). Holdings up 1% to 533,845 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 7, 2026 |
| Aug 7, 2026 | Purchase (code P) | Michele A. Anderson (Chief Development Officer) bought 1,111 shares at $18.00 ($20K), reported as a purchase (code P). Holdings up <1% to 332,161 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 7, 2026 |
| Aug 7, 2026 | Purchase (code P) | Travis Murdoch (CEO and Director) bought 83,333 shares at $18.00 ($1.5M), reported as a purchase (code P). Holdings up 3% to 2,940,670 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 7, 2026 |
| Aug 7, 2026 | Purchase (code P) | David Charles Lubner (Director) bought 55,555 shares at $18.00 ($1.0M), reported as a purchase (code P). New position of 55,555 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 7, 2026 |
14 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
8 insiders bought in 30 days
$89.2M in purchases since Aug 7, 2026 · Purchases traded Aug 7, 2026 to Aug 7, 2026 · Closed
| Insider | Value | Traded | Source |
|---|---|---|---|
| David Charles Lubner (Director) | $1.0M | Aug 7, 2026 | SEC filing |
| Travis Murdoch (CEO) | $1.5M | Aug 7, 2026 | SEC filing |
| Michele A. Anderson (Chief Development Officer) | $20K | Aug 7, 2026 | SEC filing |
| David I Malek (Director) | $75K | Aug 7, 2026 | SEC filing |
| Christopher Viehbacher (Director) | $1.5M | Aug 7, 2026 | SEC filing |
| James Paul Rickey (CFO) | $500K | Aug 7, 2026 | SEC filing |
| Forbion Growth III Management B.V. (10% owner) | $64.8M | Aug 7, 2026 | SEC filing |
| Marc L Andreessen (10% owner) | $19.8M | Aug 7, 2026 | SEC filing |
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow BRVE in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.